Federal Trade Commission
FROM Richard Feinstein
Expiring Patents, Drug Prices and the Hazy Market for Generics Patents are about to expire on two of the world's best-selling prescription drugs. Prices for cholesterol-fighter Lipitor and the blood-thinner Plavix are likely to drop by 80 percent when they're replaced by generics. But that's not all. The drug industry will be faced with an unprecedented wave of expiring patents in the next few years. What will the expiration of patents on many other drugs mean for Big Pharma? How is the industry fighting back? Will consumers get the benefits they deserve?
Mixed Messages from US diplomats on the new hard line on Syria Since President Trump's surprise retaliation against Syria's use of chemical weapons, Bashar al-Assad has used the same airport to launch conventional attacks on his own people. It's not clear what the US, its allies — or Vladimir Putin's Russia -- plan to do now.
Trump's ethical conflicts pile up as transparency diminishes President Trump's refusal to reveal his income tax returns is just one example of a lack of transparency that could be hiding conflicts of interest. Other conflicts are already obvious from his appointments. And he's being sued for using his job to increase his profits.